Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...
Hosted on MSN
Trial reveals twice as many men recover erectile function after improved prostate cancer surgery
The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in The Lancet Oncology, raise the prospect of major quality of ...
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...
More than 80 percent of prostate cancer patients develop erectile dysfunction (ED), regardless of whether they have surgery or external radiation therapy, according to a recent study published in the ...
Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...
Testosterone testing and treatment have increased significantly over the past 2 decades, yet clinical practices remain inconsistent. 1,2 Despite rising awareness and prescription trends, up to 25% of ...
No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment. Oral drugs to treat erectile dysfunction after radical treatment for ...
On TikTok, a pelvic floor exercise long popular with women is being repackaged as a fix for erectile dysfunction (ED) in ...
The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in TheLancet Oncology, raise the prospect of major quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results